Cargando…

Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation

Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Bilal, Rehman, Muneeb U., Amin, Insha, Mir, Manzoor ur Rahman, Ahmad, Sheikh Bilal, Farooq, Adil, Muzamil, Showkeen, Hussain, Ishraq, Masoodi, Mubashir, Fatima, Bilques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260481/
https://www.ncbi.nlm.nih.gov/pubmed/30532634
http://dx.doi.org/10.1016/j.jsps.2018.07.001
_version_ 1783374802396905472
author Ahmad, Bilal
Rehman, Muneeb U.
Amin, Insha
Mir, Manzoor ur Rahman
Ahmad, Sheikh Bilal
Farooq, Adil
Muzamil, Showkeen
Hussain, Ishraq
Masoodi, Mubashir
Fatima, Bilques
author_facet Ahmad, Bilal
Rehman, Muneeb U.
Amin, Insha
Mir, Manzoor ur Rahman
Ahmad, Sheikh Bilal
Farooq, Adil
Muzamil, Showkeen
Hussain, Ishraq
Masoodi, Mubashir
Fatima, Bilques
author_sort Ahmad, Bilal
collection PubMed
description Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes.
format Online
Article
Text
id pubmed-6260481
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62604812018-12-07 Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation Ahmad, Bilal Rehman, Muneeb U. Amin, Insha Mir, Manzoor ur Rahman Ahmad, Sheikh Bilal Farooq, Adil Muzamil, Showkeen Hussain, Ishraq Masoodi, Mubashir Fatima, Bilques Saudi Pharm J Article Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes. Elsevier 2018-12 2018-07-29 /pmc/articles/PMC6260481/ /pubmed/30532634 http://dx.doi.org/10.1016/j.jsps.2018.07.001 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ahmad, Bilal
Rehman, Muneeb U.
Amin, Insha
Mir, Manzoor ur Rahman
Ahmad, Sheikh Bilal
Farooq, Adil
Muzamil, Showkeen
Hussain, Ishraq
Masoodi, Mubashir
Fatima, Bilques
Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
title Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
title_full Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
title_fullStr Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
title_full_unstemmed Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
title_short Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
title_sort zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: probable role of nf-kb activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260481/
https://www.ncbi.nlm.nih.gov/pubmed/30532634
http://dx.doi.org/10.1016/j.jsps.2018.07.001
work_keys_str_mv AT ahmadbilal zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT rehmanmuneebu zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT amininsha zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT mirmanzoorurrahman zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT ahmadsheikhbilal zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT farooqadil zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT muzamilshowkeen zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT hussainishraq zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT masoodimubashir zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation
AT fatimabilques zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation